Trials / Not Yet Recruiting
Not Yet RecruitingNCT06898203
Precision Imaging to Evaluate Kaposi Sarcoma
Phase II - Precision Imaging to Evaluation Kaposi Sarcoma (PRIME-KS)
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 300 (estimated)
- Sponsor
- Washington University School of Medicine · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
AIMS 2 \& 3: In this study the investigators seek to formally compare reproducibility and accuracy of KS lesion size measurements between SkinScan3D and the current standard of care manual measurement method. The investigators will then test the SS3D device on 100 patients in a variety of real-world practice locations to determine whether the device will be usable, acceptable, appropriate, and feasible in routine care settings.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | SkinScan3D | A handheld, simple, low-cost, and user-friendly technology that combines liquid lens technology and artificial intelligence (AI). |
Timeline
- Start date
- 2026-05-31
- Primary completion
- 2028-11-30
- Completion
- 2029-11-30
- First posted
- 2025-03-27
- Last updated
- 2026-03-13
Locations
2 sites across 2 countries: Kenya, Uganda
Source: ClinicalTrials.gov record NCT06898203. Inclusion in this directory is not an endorsement.